Moderna Files 2024 10-K
Ticker: MRNA · Form: 10-K · Filed: Feb 21, 2025 · CIK: 1682852
| Field | Detail |
|---|---|
| Company | Moderna, Inc. (MRNA) |
| Form Type | 10-K |
| Filed Date | Feb 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, biotech, financials
TL;DR
Moderna's 2024 10-K is in. Full financials and biz ops details for the year.
AI Summary
Moderna, Inc. filed its 10-K for the fiscal year ending December 31, 2024, on February 21, 2025. The company, headquartered at 325 Binney Street, Cambridge, MA, is a leader in biological products, specifically mRNA therapeutics. The filing details its financial performance and business operations for the year.
Why It Matters
This 10-K filing provides investors and the public with a comprehensive overview of Moderna's financial health, strategic direction, and potential risks for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a biotechnology company, Moderna faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (The period covered by the 10-K filing.)
- 2023 — Prior Fiscal Year (For comparison with the current fiscal year's performance.)
Key Players & Entities
- Moderna, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-21 (date) — Filing date
- 325 Binney Street, Cambridge, MA (location) — Company business address
FAQ
What is Moderna's primary business as indicated by its SIC code?
Moderna's Standard Industrial Classification (SIC) code is 2836, which corresponds to 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
When was Moderna's name changed from Moderna Therapeutics, Inc.?
The date of the name change from Moderna Therapeutics, Inc. to Moderna, Inc. was August 22, 2016.
What is the SEC file number for Moderna?
Moderna's SEC file number is 001-38753.
What is the filing date of this 10-K report?
This 10-K report was filed as of February 21, 2025.
What is the fiscal year end for Moderna?
Moderna's fiscal year ends on December 31.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 21, 2025 regarding Moderna, Inc. (MRNA).